Coastal Bridge Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$416K Buy
1,484
+1
+0.1% +$263 0.03% 343
2026
Q1
$396K Sell
1,483
-207
-12% -$56.1K 0.03% 340
2025
Q4
$424K Buy
1,690
+33
+2% +$8.76K 0.03% 327
2025
Q3
$476K Sell
1,657
-17
-1% -$4.55K 0.04% 305
2025
Q2
$439K Buy
1,674
+18
+1% +$4.38K 0.04% 305
2025
Q1
$385K Buy
1,656
+188
+13% +$45.6K 0.03% 314
2024
Q4
$337K Hold
1,468
– – 0.08% 109
2024
Q3
$328K Hold
1,468
– – 0.08% 112
2024
Q2
$299K Buy
+1,468
New +$299K 0.07% 115

Other funds holding LH

Coastal Bridge Advisors's LH Position: Q2 2026 in Review

Coastal Bridge Advisors increased its Labcorp (LH) stake by 0.07% in Q2 2026, buying an estimated $263 and bringing the position to 1,484 shares worth $416K. The position accounts for 0.03% of the portfolio, ranked #343.

Coastal Bridge Advisors first reported a position in LH in Q2 2024 and has held it in 9 quarters since. The position peaked at $476K in Q3 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Coastal Bridge Advisors held 1,484 shares of Labcorp worth $416K as of Q2 2026.
  • Coastal Bridge Advisors bought 1 Labcorp share in Q2 2026, an estimated $263.
  • Labcorp made up 0.03% of Coastal Bridge Advisors's portfolio in Q2 2026, its #343 holding.
  • Coastal Bridge Advisors first reported a position in Labcorp in Q2 2024 and has held it in 9 quarters since.
  • Coastal Bridge Advisors's Labcorp position peaked at $476K in Q3 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Coastal Bridge Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.